Giuseppina Marcuccio

Dr. Giuseppina Marcuccio

University of Campania "Luigi Vanvitelli", Caserta, Campania, Italy
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
Pasquale AmbrosinoPasquale Ambrosino
Pasquale Ambrosino
Ilenia Lorenza CalcaterraIlenia Lorenza Calcaterra
Ilenia Lorenza Calcaterra
MMMarco Mosella
Marco Mosella
RFRoberto Formisano
Roberto Formisano
SDsilvestro ennio D'anna
silvestro ennio D'anna
Mauro ManiscalcoMauro Maniscalco
Mauro Maniscalco
The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) generated a worldwide emergency, until the declaration of the pandemic in March 2020. SARS-CoV-2 could be responsible for coronavirus disease 2019 (COVID-19), which goes from a flu-like illness to a potentially fatal condition that needs intensive care. Furthermore, the persistence of functional disability and long-term cardiovascular sequelae in COVID-19 survivors suggests that convalescent patients may suffer from post-acute COVID-19 syndrome, requiring long-term care and personalized rehabilitation. However, the pathophysiology of acute and post-acute manifestations of COVID-19 is still under study, as a better comprehension of these mechanisms would ensure more effective personalized therapies. To date, mounting evidence suggests a crucial endothelial contribution to the clinical manifestations of COVID-19, as endothelial cells appear to be a direct or indirect preferential target of the virus. Thus, the dysregulation of many of the homeostatic pathways of the endothelium has emerged as a hallmark of severity in COVID-19. The aim of this review is to summarize the pathophysiology of endothelial dysfunction in COVID-19, with a focus on personalized pharmacological and rehabilitation strategies targeting endothelial dysfunction as an attractive therapeutic option in this clinical setting.

1 February 2020 in International Journal of Pediatric Otorhinolaryngology
Verified
Journal Article
Closed access
Domenico TestaDomenico Testa
Domenico Testa
Matteo Di BariMatteo Di Bari
Matteo Di Bari
MNMichele Nunziata
Michele Nunziata
GCGeneroso De. Cristofaro
Generoso De. Cristofaro
GMGiuseppe Massaro
Giuseppe Massaro
GMGaetano Motta
Gaetano Motta

26 October 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
PMPasquale Moretta
Pasquale Moretta
NCNicola Davide Cavallo
Nicola Davide Cavallo
CCClaudio Candia
Claudio Candia
ALAnna Lanzillo
Anna Lanzillo
Giuseppina MarcuccioGiuseppina Marcuccio
Giuseppina Marcuccio
Mauro ManiscalcoMauro Maniscalco
Mauro Maniscalco
Chronic obstructive pulmonary disease (COPD) is a debilitating lung disease characterized by chronic airflow limitation and persistent respiratory symptoms. It is a major cause of morbidity and mortality worldwide, significantly impacting healthcare systems with considerable socioeconomic consequences. The main risk factors include exposure to tobacco smoke, environmental pollutants, occupational dust, and genetic factors such as alpha-1 antitrypsin deficiency. COPD is often associated with extrapulmonary comorbidities, particularly psychiatric disorders like depression and anxiety, which worsen patients’ quality of life and prognosis. The prevalence of these disorders in patients with COPD varies significantly but is always higher than in healthy controls. Psychiatric disorders can negatively influence COPD management and vice versa, creating a complex bidirectional interaction. Depression and anxiety are the most common psychiatric comorbidities in patients with COPD, influenced by factors such as social isolation, physical limitations, and fear of exacerbations. Diagnosis of these psychiatric disorders is complicated by the overlap of symptoms with those of COPD. However, some screening tools can facilitate early detection. The treatment of psychiatric disorders in patients with COPD in a rehabilitation setting requires a multidisciplinary approach involving pulmonologists, neurologists and psychologists. Pharmacological therapy with antidepressants shows mixed results in terms of efficacy and safety, with some studies reporting benefits on quality of life and others suggesting an increased risk of exacerbations and pneumonia. An integrated approach that includes the assessment and intervention of mental disorders is essential to improve the overall management of COPD and the quality of life of patients. This narrative review provides an overview of the main psychiatric comorbidities in COPD patients, aiming to fill gaps in the literature and suggest areas for future research.

12 April 2012 in Acta Oto-Laryngologica
Verified
Journal Article
Closed access
PDF file
Domenico TestaDomenico Testa
Domenico Testa
GGGermano Guerra
Germano Guerra
Giuseppina MarcuccioGiuseppina Marcuccio
Giuseppina Marcuccio
PLPasquale Gianluca Landolfo
Pasquale Gianluca Landolfo
GMGaetano Motta
Gaetano Motta
The high oxidant levels in chronic otitis media with effusion (OME) observed in our research and the improvement seen in children with chronic OME after antioxidant treatment suggest that oxygen-derived free radicals play an important role in chronic OME. OME is a common pathologic condition characterized by nonpurulent fluid in the middle ear (ME) that leads to moderate conductive hearing loss and flat tympanogram. During OME inflammatory cells generate large amounts of superoxide radicals to improve bactericidal activity. Overproduction of oxygen-derived free radicals induces oxidative damage in humans. Glutathione (GSH) is one of the major components of the antioxidant system that protects cells from oxidative stress. The aim of the study was to evaluate oxidative stress in chronic OME by investigation of ME fluids collected during myringotomy. During myringotomy, fluid was collected from the ME to evaluate lipid peroxide levels in the effusion. Fifty-nine children with ME effusion without any resolution after repeated medical treatments were enrolled in the study. Lipid peroxide levels in all samples were high (mean 11.5 nmole/million cells), similar to the values found in other chronic diseases. GSH might be employed during surgery while applying ventilation tubes and after surgery to prevent oxidative stress.

1 April 2020 in Acta Otorhinolaryngologica Italica
Verified
Journal Article
Open access
PDF file
Domenico TestaDomenico Testa
Domenico Testa
Marco CarotenutoMarco Carotenuto
Marco Carotenuto
FPFrancesco Precenzano
Francesco Precenzano
ARAlessia Russo
Alessia Russo
ADAnna Donadio
Anna Donadio
GMGaetano Motta
Gaetano Motta
Obstructive sleep apnoea syndrome (OSAS) is the most severe form of sleep-related disordered breathing (SRDB) and is characterised by snoring, apnoeas, and/or hypopnoeas associated to hypoxia, hypercarbia, or repeated arousals from sleep. OSAS has three major categories of morbidities: neurobehavioural, cardiovascular and somatic growth failure. The gold standard for objective diagnosis of obstructive-SRDB severity is polysomnography (PSG). The indication for surgical treatment in children is moderate-severe OSAS (AHI, apnoea hypopnoea index > 5/h) and in mild OSAS (AHI 2-5/h) with complications or morbidity. The entire spectrum of PSG-defined SRDB (ranging from Primary Snoring to severe OSAS) may correlate with behavioural, attentional and executive function deficits relating to hypoxia and sleep disruption: in some cases, these alterations may mimic attention deficit hyperactivity disorder (ADHD). The aim of this research was to evaluate visuoperceptual and constructional abilities, paediatric sleep questionnaire and polysomnographic scores before and 6 months after adenotonsillectomy with objective and subjective information. We included 59 children who underwent neuropsychiatric and otolaryngologist clinical evaluation and the Beery-Buktenica Developmental Test of Visual-Motor Integration (VMI); children parents were asked to fill in the Paediatric Sleep Questionnaire (PSQ); each child underwent PSG. At 6 months after adenotonsillectomy, all patients were evaluated again. There is a significant difference in PSQ parameters, VMI standard, visual tests scores and PSG parameters before and after adenotonsillectomy in children affected by OSAS. These results showed the achievement of therapeutic benefits with improvement of the quality of life for both children and their parents.

25 November 2016 in Aging Clinical and Experimental Research
Verified
Journal Article
Closed access
PDF file
Domenico TestaDomenico Testa
Domenico Testa
Giuseppina MarcuccioGiuseppina Marcuccio
Giuseppina Marcuccio
GPGiorgio Panin
Giorgio Panin
ABAndrea Bianco
Andrea Bianco
DTDomenico Tafuri
Domenico Tafuri
GMGaetano Motta
Gaetano Motta